Tag Archives: PML
Does immunotherapy in Multiple Sclerosis increase the risk of developing PML?
Progressive multifocal leukoencephalopathy (PML) is a rare and life-threatening brain disease caused by the JC virus. In multiple sclerosis (MS), natalizumab (Tysabri, Biogen) was already known to substantially increase the risk for PML by suppressing the immune
